Moderna will build its first mRNA production facility in Kenya, investing up to US$500m.
COVID-19
The former mRNA start-up Moderna Inc is set to expand its commercial network in six European nations to become...
AGC Biologics supports BioNTech's manufacturing of an Omicron-based vaccine with plasmids for in vitro...
The EU Commission and AstraZeneca have settled their ongoing legal dispute over the supply of COVID-19 vaccine...
Vaccine maker Valneva SE announced the initiation of a further Phase III trial for its COVID-19 vaccine...
U.S. government to purchase at not-for-profit price 200 million doses in 2021 and 300 million in the first...
Share
